VATS and Pneumonia: Key Considerations

Pneumonia as a VATS Complication

The British Thoracic Society notes that pneumonia and persistent air leak complications are greater following VATS compared to intercostal chest drain alone when treating primary spontaneous pneumothorax 1

VATS demonstrates significantly lower overall perioperative morbidity compared to open thoracotomy, including reduced rates of atrial arrhythmias and cardiovascular complications 2
In elderly patients (>80 years), postoperative mortality with VATS remains remarkably low at <2% compared to higher rates with open procedures 2

Proceed with VATS when treating complicated parapneumonic effusion or empyema that has failed medical management, as recommended by the guideline society 3
Managing recurrent pneumothorax where prevention of future episodes outweighs the pneumonia risk, according to the British Thoracic Society 1

Standard prophylaxis includes cefazolin 1-2g IV every 8 hours or cefuroxime 1.5g IV every 8 hours covering skin flora, as recommended by the guideline society 3
Add MRSA coverage (vancomycin 15-20 mg/kg IV every 8-12 hours) if prior antibiotic use within 90 days, prolonged hospitalization ≥5 days, or local MRSA prevalence >10-20%, as suggested by the guideline society 3
Poor functional capacity (<4 METs) predicts 18.7-fold increased mortality risk and warrants aggressive preoperative optimization, according to the guideline society 2

Obtain tracheal aspirates for Gram stain and culture, plus viral pathogen testing (including influenza), at the time of initial endotracheal tube placement if mechanical ventilation is required, as recommended by the Infectious Diseases Society of America 7
Initiate empiric broad-spectrum antibiotics: vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 4.5g IV every 8 hours or cefepime 2g IV every 8 hours, as suggested by the guideline society 3
Narrow antibiotics based on culture results within 48-72 hours to prevent resistance development, according to the guideline society 3

Conversion rates of 0-12% should not be considered failure but rather a safety resource when intraoperative complications arise, as noted by the guideline society 2
Delayed surgical intervention in empyema increases risk of chronic pleural thickening, restrictive lung disease, and need for more extensive surgery, according to the guideline society 3
Early definitive surgery within 7 days of failed medical management results in lower rates of chronic disability, as recommended by the guideline society 3
Five-year survival after VATS lobectomy in patients with severe COPD (PPO FEV1 <40%) is 35%, which exceeds expected survival without resection despite the pneumonia risk, as reported by the American College of Chest Physicians 5